Saga Johansson

Saga Johansson works in Preventive Cardiology affiliated with AstraZeneca (United Kingdom).

Saga Johansson is a researcher currently affiliated with AstraZeneca in Cambridge, United Kingdom. She is also associated with the University of Gothenburg in Sweden, where she has contributed to preventive cardiology research. Her publications include studies on mortality trends in myocardial infarction survivors and risks associated with low-dose aspirin in cardiovascular prevention.